Hotchkis & Wiley Capital Management’s Quest Diagnostics DGX Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-983,900	Closed	-$66M	–	191
2014 Q4	$66M	Sell	983,900 -609,362	-38%	-$38.5M	0.23%	94
2014 Q3	$96.7M	Sell	1,593,262 -930,138	-37%	-$57.3M	0.35%	75
2014 Q2	$148M	Buy	2,523,400 +27,900	+1%	+$1.63M	0.52%	63
2014 Q1	$145M	Buy	2,495,500 +477,900	+24%	+$25.6M	0.54%	58
2013 Q4	$108M	Sell	2,017,600 -78,300	-4%	-$4.64M	0.46%	66
2013 Q3	$130M	Buy	2,095,900 +801,600	+62%	+$48M	0.6%	55
2013 Q2	$78.5M	Buy	+1,294,300	New	+$77.1M	0.39%	75

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Hotchkis & Wiley Capital Management's DGX Position: Q1 2015 in Review

Hotchkis & Wiley Capital Management sold out of Quest Diagnostics (DGX) in Q1 2015, closing a stake of 983,900 shares — an estimated $66M sold.

Hotchkis & Wiley Capital Management first reported a position in DGX in Q2 2013 and held it in 7 quarters. The position peaked at $148M in Q2 2014. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

Hotchkis & Wiley Capital Management reported no remaining Quest Diagnostics position as of Q1 2015 after selling out during the quarter.
Hotchkis & Wiley Capital Management sold 983,900 Quest Diagnostics shares in Q1 2015, an estimated $66M.
Hotchkis & Wiley Capital Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 7 quarters.
Hotchkis & Wiley Capital Management's Quest Diagnostics position peaked at $148M in Q2 2014.
553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2015, filed 15 May 2015.